Dave Gancarz | executive |
Robert Duggan | executive |
Mahkam Zanganeh | executive |
Manmeet Soni | executive |
Dara Azar | analyst |
Allen Yang | executive |
Yigal Nochomovitz | analyst |
Mitchell Kapoor | analyst |
Good morning, and welcome to Summit Therapeutics Second Quarter 2024 Earnings and Update Call. [Operator Instructions] Please note that today's call is being recorded. And at this time, I would like to turn the call over to Dave Gancarz, Summit Therapeutics' Chief Business and Strategy Officer.
You may proceed.
Good morning, and thank you for joining us.